The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR...

por You, Liangshun, Liu, Hui, Huang, Jian, Xie, Wanzhuo, Wei, Jueying, Ye, Xiujin, Qian, Wenbin
Publicado 2016

PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242

por Yang, Chunmei, Huang, Xianbo, Liu, Hui, Xiao, Feng, Wei, Jueying, You, Liangshun, Qian, Wenbin
Publicado 2017